backgroundtobacco
relat
lung
diseas
includ
chronic
obstruct
pulmonari
diseas
copd
major
caus
lungrel
disabl
death
worldwid
acut
exacerb
copd
aecopd
commonli
associ
upper
lower
respiratori
viral
infect
may
result
respiratori
failur
advanc
lung
diseas
objectivew
sought
determin
mechan
underli
copd
exacerb
host
respons
pathogenderiv
factor
methodsov
month
period
assess
viral
caus
upper
lower
respiratori
infect
copd
control
subject
collect
nasal
bronchoalveolar
lavag
bal
fluid
peripher
blood
baselin
exacerb
condit
determin
effect
human
rhinoviru
hrv
proteinas
cell
activ
human
mice
resultshrv
isol
nasal
lung
fluid
subject
aecopd
bal
fluid
cell
copd
patient
exhibit
type
helper
cell
cytokin
phenotyp
acut
infect
hrvencod
proteinas
activ
monocytederiv
dendrit
cell
vitro
induc
strong
immun
respons
cell
intranas
chronic
obstruct
pulmonari
diseas
copd
character
irrevers
reduct
maximum
expiratori
airflow
current
fourth
lead
caus
death
us
worldwid
copd
th
preval
diseas
estim
rise
th
next
two
decad
frequent
hospit
clinicbas
visit
treatment
episod
worsen
short
breath
account
larg
proport
medic
expenditur
portend
poor
outcom
patient
copd
respiratori
tract
infect
lead
caus
morbid
hospit
antibiot
use
patient
chronic
lung
diseas
particular
copd
howev
past
etiolog
agent
respons
respiratori
failur
remain
obscur
case
viral
infect
evok
strong
type
helper
andor
cytotox
lymphocyt
ctl
respons
requir
effici
erad
organ
howev
number
respiratori
virus
includ
hrv
associ
compar
weak
immun
robust
allerg
inflamm
immun
previous
link
immunopatholog
copd
emphysema
whether
respiratori
viral
infect
exacerb
immun
evok
aberr
system
lungspecif
respons
remain
unclear
major
difficulti
understand
etiolog
aecopd
mechan
respiratori
failur
occur
acut
worsen
airway
obstruct
patient
advanc
copd
clearli
link
increas
work
breath
reminisc
acut
exacerb
asthma
other
shown
presenc
activ
proteinas
environment
relev
allergen
critic
develop
allerg
respons
induc
symptom
airway
obstruct
human
experiment
asthma
inde
neutral
proteinas
render
allergen
inact
absenc
proteolyt
activ
allergen
fail
induc
requisit
lung
respons
previous
demonstr
dendrit
cell
activ
allergen
proteinas
induc
cell
differenti
studi
investig
whether
host
immun
respons
rhinovir
proteinas
could
contribut
immunopatholog
diseas
exacerb
link
acut
viral
infect
copd
show
hrv
link
aecopd
person
advanc
lung
diseas
moreov
demonstr
rhinovir
proteinas
potent
immunomodulatori
activ
human
dendrit
cell
favor
product
cytokin
cell
peripher
system
rhinovir
proteinas
induc
allerg
diseas
mice
administ
upper
respiratori
tract
togeth
find
support
mechan
aecopd
proteinas
deriv
rhinoviru
potenti
virus
could
creat
allerg
lung
immun
environ
lead
airway
obstruct
induc
cellderiv
cytokin
clinic
demograph
characterist
subject
shown
onlin
repositori
tabl
recruit
subject
part
longitudin
exacerb
studi
copd
lescopd
time
enrol
subject
free
respiratori
symptom
histori
antibiot
use
system
corticosteroid
past
week
peripher
blood
nasal
throat
swab
sampl
collect
subject
initi
enrol
time
acut
exacerb
copd
aecopd
copd
exacerb
defin
respiratori
ill
mark
presenc
symptom
rhiniti
pharyng
increas
cough
short
breath
sputum
product
andor
chang
sputum
color
presenc
absenc
fever
temperatur
subject
underw
bronchoscopi
clinic
stabl
altern
patient
admit
ben
taub
gener
hospit
diagnosi
aecopd
place
ventil
support
underw
bronchoscopi
alveolar
fluid
lavag
sampl
describ
previous
studi
approv
institut
review
board
baylor
colleg
medicin
written
inform
consent
obtain
studi
particip
nasal
throat
swab
sampl
collect
lescopd
particip
onlin
repositori
tabl
time
entri
studi
baselin
episod
aecopd
use
commerci
avail
rapid
multiplex
pcr
system
multicodeplx
system
eragen
bioscienc
madison
wi
detect
seventeen
set
respiratori
virus
includ
human
rhinoviru
hrv
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
influenza
viru
infv
metapneumoviru
adenoviru
ad
coronaviru
enteroviru
accord
manufactur
instruct
describ
previous
bronchoalveolar
fluid
bal
sampl
obtain
intub
subject
admit
micu
ben
taub
gener
hospit
aecopd
clinic
stabl
copd
patient
control
subject
describ
previous
concentr
cytokin
bal
fluid
detect
use
antibodybas
standard
elisa
luminex
assay
briefli
total
protein
bal
sampl
measur
sampl
normal
lowest
protein
concentr
use
standard
protein
measur
assay
pierc
bca
protein
assay
thermo
scientif
usa
standard
elisa
detect
biorad
beadlyt
multiplex
assay
millipor
charlottesvil
virginia
detect
cytokin
use
measur
supernat
concentr
accord
manufactur
r
system
bd
bioscienc
analysi
vitro
cell
activ
use
cell
deplet
pbmc
well
irradi
rad
use
antigen
present
cell
apc
final
volum
cocultur
autolog
cell
day
supernat
remov
well
store
batch
cytokin
analysi
use
biorad
monocytederiv
mo
dc
gener
previous
describ
cell
posit
select
pbmc
isol
subject
evid
aecopd
use
microbead
separ
use
automac
miltenyi
biotec
induc
dc
differenti
cell
cultur
complet
medium
rpmi
fb
iuml
human
rgmcsf
r
system
iuml
human
r
system
six
day
nonadher
immatur
dc
harvest
gentl
pipet
two
wash
pb
experi
modc
cultur
lp
recombin
rhinoviru
proteinas
buffer
vehicl
control
hr
surfac
express
dc
matur
marker
hladr
detect
fitc
pe
apcconjug
hladr
mab
respect
bd
bioscienc
analyz
multicolor
facscalibur
flow
cytomet
bd
bioscienc
flowjo
softwar
describ
rhinovir
proteinas
obtain
use
recombin
protein
previous
describ
cell
posit
select
use
microbead
miltenyi
biotec
use
automac
accord
manufactur
instruct
cocultur
autolog
modc
condit
proteinas
lp
buffer
ratio
six
day
plate
expand
cell
wash
stimul
immobil
mab
h
cultur
supernat
collect
cytokin
product
assess
beadlyt
multiplex
assay
millipor
wild
type
mice
purchas
baylor
center
compar
medicin
facil
kept
associ
assess
accredit
laboratori
anim
care
aalac
accredit
transgen
anim
facil
baylor
colleg
medicin
experi
preform
accord
protocol
approv
institut
anim
care
use
committe
baylor
colleg
medicin
mice
given
ug
chicken
egg
ovalbumin
ova
intranas
rhinovir
proteinas
vehicl
buffer
pb
everi
day
total
day
twenti
four
hr
follow
last
challeng
mice
anesthet
intub
tail
intraven
iv
start
respiratori
system
resist
measur
use
provoc
concentr
acetylcholin
milligram
per
gram
caus
percent
increas
airway
resist
baselin
describ
lung
wash
use
two
ml
aliquot
steril
pb
tracheal
cannula
bronchoalveolar
lavag
bal
fluid
total
differenti
cell
count
measur
use
standard
hemocytomet
giemsa
stain
cytospin
slide
lungderiv
singl
cell
use
elispot
cultur
supernat
collect
day
store
batch
analysi
use
elisa
andor
biorad
multiplex
beadbas
cytokin
detect
kit
biorad
previous
describ
recombin
protein
captur
antibodi
correspond
biotinconjug
detect
antibodi
purchas
r
system
bd
bioscienc
tnf
concentr
measur
lincoplex
millipor
glycoprotein
measur
lung
lavag
fluid
describ
previous
comparison
control
copd
bal
cell
cytokin
chemokin
concentr
analysi
use
oneway
anova
test
wilcoxon
match
pair
test
nonparametr
twotail
comparison
unpair
data
mannwhitney
test
nonparametr
twotail
use
respiratori
virus
among
import
trigger
acut
exacerb
copd
aecopd
therefor
determin
viral
etiolog
upper
lower
respiratori
infect
prospect
volunt
particip
lescopd
studi
collect
nasal
throat
swab
sampl
volunt
initi
enrol
time
aecopd
see
method
definit
aecopd
respiratori
viral
infect
identifi
use
high
throughput
multiplexbas
assay
simultan
identifi
respiratori
virus
subtyp
multicodeplx
eragen
bioscienc
madison
wi
total
ill
episod
period
includ
subject
seen
acut
ill
identifi
found
consist
other
prior
observ
major
exacerb
occur
advanc
copd
gold
criteria
iiiiv
case
compar
subject
mild
copd
iii
case
diseas
control
case
sampl
volunt
baselin
time
entri
le
copd
fail
yield
pcr
evid
viral
infect
contrast
thirteen
sampl
collect
return
visit
aecopd
pcrposit
virus
major
rhinoviru
onlin
repositori
tabl
addit
bronchoalveolar
bal
fluid
sampl
intub
subject
aecopd
posit
respiratori
viru
infect
onlin
repositori
tabl
thu
common
respiratori
virus
especi
hrv
specif
link
presenc
aecopd
stabl
diseas
condit
lymphocyt
extract
lung
parenchyma
patient
moder
sever
copd
spontan
secret
predomin
cytokin
chemokin
understand
lung
immun
profil
aecopd
determin
cytokin
profil
bal
fluid
normal
total
protein
concentr
copd
patient
stabl
exacerb
condit
compar
control
subject
fig
contrast
find
peripher
lung
lymphocyt
studi
vitro
found
half
subject
group
detect
bal
fluid
although
higher
concentr
cytokin
detect
subject
aecopd
reach
statist
signific
fig
similarli
differ
concentr
bal
fluid
found
fig
howev
detect
significantli
higher
concentr
canon
cytokin
bal
fluid
subject
aecopd
subject
group
produc
cytokin
fig
latter
find
unexpect
other
previous
shown
lung
immun
phenotyp
subject
stabl
copd
emphysema
highli
bias
cell
extract
lung
patient
copd
emphysema
specif
secret
nonetheless
higher
concentr
mig
two
specif
chemokin
induc
present
bal
subject
aecopd
fig
e
togeth
data
reconcil
lack
bal
previou
find
copd
patient
bias
immun
respons
aecopd
find
suggest
immun
respons
may
aris
set
aecopd
possibl
influenc
respiratori
function
next
determin
whether
immun
phenotyp
peripher
blood
cell
isol
aecopd
alter
compar
individu
baselin
condit
spontan
cytokin
releas
pbmcderiv
cell
determin
cocultur
autolog
antigen
present
cell
two
distinct
condit
baselin
free
respiratori
symptom
exacerb
episod
order
determin
cell
immun
respons
time
respiratori
infect
compar
cytokin
baselin
upper
lower
respiratori
infect
urilri
control
copd
exacerb
mild
moder
copd
iii
advanc
diseas
copd
iiiiv
group
defin
revis
gold
criteria
cultur
cell
baselin
time
urilri
subject
control
aecopd
mild
moder
copd
iii
show
signific
chang
product
fig
b
product
significantli
increas
time
respiratori
infect
mild
moder
diseas
fig
despit
lack
detect
bal
fluid
aecopd
subject
pbmcderiv
cell
advanc
lung
diseas
copd
iiiiv
secret
significantli
higher
amount
compar
stabl
condit
fig
respect
agreement
cytokin
find
bal
fluid
analys
aecopd
subject
pbmcderiv
cell
aecopd
copd
iiiiv
secret
significantli
higher
amount
compar
group
stabl
period
fig
could
detect
express
vitro
cocultur
condit
indic
extrem
low
concentr
cyokin
physiolog
condit
find
indic
two
cytokin
name
cyttokin
associ
local
system
immun
respons
advanc
copd
present
upper
lower
respiratori
tract
infect
next
sought
examin
mechan
underli
induct
cell
viral
infect
chose
studi
rhinoviru
proteinas
allergen
potenti
microbi
proteinas
establish
link
aecopd
case
rhinoviru
infect
condit
monocyt
mo
deriv
dc
modc
stimul
hr
respons
rhinoviru
proteinas
result
signific
upregul
mhc
class
ii
hladr
compar
control
vehicl
lp
stimul
fig
b
respect
analysi
cytokin
secret
condit
reveal
signific
increas
tnf
product
modc
activ
proteinas
signific
differ
found
secret
fig
data
shown
find
indic
viral
proteinas
induc
matur
modc
potenti
alter
function
next
determin
function
signific
rhinoviru
proteinas
activ
modc
cell
activ
proteinas
lp
activ
modc
induc
greater
secret
cocultur
cell
fig
find
agreement
bal
fluid
analysi
patient
aecopd
show
addit
signific
immun
bia
well
fig
togeth
data
suggest
mechan
rhinoviru
proteinas
induc
matur
activ
human
modc
promot
cell
differenti
data
thu
far
point
direct
contribut
purifi
hrv
proteians
induct
skew
immun
respons
human
pbmc
therefor
next
sought
determin
whether
hrv
proteinas
could
induc
physiolog
chang
lung
consist
respons
mice
therefor
confirm
hrv
proteinas
could
induc
immun
respons
vivo
administ
ovalbumin
ova
pb
ova
vehicl
proteinas
ova
ova
use
ensur
detect
antigen
specif
marker
immun
mice
threeweek
period
use
wellestablish
model
activ
proteinas
induc
allerg
lung
diseas
proteinas
deliv
intranas
mimic
condit
like
present
activ
human
rhinoviru
upper
respiratori
tract
infect
fig
compar
ova
vehicl
challeng
intranas
challeng
result
airway
hyperreact
ahr
assess
increas
respiratori
system
resist
r
rs
respons
multipl
acetylcholin
ach
dose
decreas
provoc
concentr
ach
requir
elicit
increas
r
rs
baselin
pc
fig
data
shown
rhinoviru
proteinas
induc
robust
lung
inflamm
assess
enhanc
eosinophila
neutrophilia
whole
lung
singl
cell
analysi
elispot
techniqu
also
show
predomin
spontan
product
mice
challeng
rhinoviru
proteinas
compar
treatment
group
fig
interestingli
despit
robust
respons
proteinas
b
cell
respons
determin
detect
ovaspecif
present
mice
treat
fig
analysi
lung
lavag
fluid
group
mice
reveal
increas
glycoprotein
secret
mice
treat
proteinas
fig
comprehens
assess
cytokin
profil
elicit
viral
proteinas
lung
cell
cultur
establish
ex
vivo
luminexbas
multiplex
technolog
use
quantifi
secret
cytokin
cell
supernat
studi
show
select
increas
secret
cytokin
induc
rhinoviru
chemokin
induc
fig
tnf
exclus
upregul
proteinas
fig
data
shown
thu
rhinoviru
proteinas
elicit
secret
cytokin
allerg
lung
diseas
given
intranas
mice
studi
prospect
investig
associ
respiratori
tract
viral
infect
copd
exacerb
like
mechan
common
respiratori
tract
virus
could
induc
aberr
immun
respons
lung
use
wellcharacter
cohort
former
current
never
smoker
without
advanc
lung
diseas
previous
shown
aecopd
occur
smoker
sever
sever
copd
hrv
among
common
viral
isol
link
respiratori
infect
work
show
bal
fluid
subject
copd
respiratori
failur
show
significantli
higher
concentr
associ
chemokin
howev
unexpect
detect
albeit
low
level
canon
cytokin
provid
initi
evid
mix
respons
elicit
virus
might
contribut
respiratori
failur
seen
patient
rhinovir
proteinas
induc
cell
develop
human
cell
effect
modc
power
induc
cytokin
increas
neutrophil
esosinophil
lung
increas
airway
resist
mice
confirm
highli
immun
alter
natur
proteinas
togeth
find
suggest
proteinas
produc
hrv
elicit
respons
may
exacerb
chronic
airway
obstruct
characterist
advanc
copd
potenti
trigger
respiratori
failur
hrv
member
famili
picornavirida
among
common
caus
human
respiratori
infect
hrv
infect
normal
occur
direct
inocul
viru
ciliat
epitheli
cell
upper
airway
bind
host
intercellular
adhes
result
releas
singl
strand
viral
rna
genom
cytoplasm
immun
respons
well
describ
effect
host
immun
respons
erad
viral
infect
howev
asthmat
individu
weak
immun
respons
robust
immun
rhinoviru
infect
postul
mechan
exacerb
diseas
suscept
asthmat
although
type
immun
long
link
allerg
diseas
occasion
associ
copd
consist
link
type
cytokin
airway
obstruct
smoker
elus
moreov
type
immun
mechan
gener
requir
erad
intracellular
pathogen
virus
inde
preexist
allerg
inflamm
potenti
impair
requisit
viral
clearanc
mechan
essenti
convert
respiratori
virus
selfrepl
allergen
find
rhinovir
proteinas
could
power
induc
inflamm
thu
provid
potenti
critic
insight
pathogenesi
copd
exacerb
rhinoviru
infect
interest
note
found
increas
product
aecopd
specif
subject
sever
sever
copd
iiiiv
gold
classif
found
cytokin
gener
inhibitori
immun
respons
also
regul
aecopd
irrespect
diseas
sever
increas
acut
inflammationinfect
might
repres
natur
regulatori
respons
limit
cell
activ
follow
initi
viral
infect
nonetheless
induc
lower
respiratori
tract
type
immun
respons
rhinovir
proteinas
like
induc
second
compon
airway
obstruct
mediat
loss
lung
structur
integr
proobstruct
effect
andor
ie
airway
hyperrespons
airway
mucu
hypersecret
moreov
hrv
like
gain
immun
deviat
catalyz
proteinas
asthma
type
immun
induc
viral
proteinas
may
impair
otherwis
effici
type
immun
clearanc
mechan
lead
prolong
infect
enhanc
spread
microorgan
point
specul
propos
acceler
product
proteinas
may
evolv
strategi
enhanc
process
polyprotein
sinc
interfer
lead
decreas
viral
titer
howev
modul
host
immun
respons
may
maxim
much
lower
level
proteinas
product
may
promot
diseas
dissemin
put
viraladapt
mechan
littl
consequ
host
normal
respiratori
function
unfortun
peril
sever
copd
respiratori
compromis
clinic
studi
copd
exacerb
shown
inhibit
immun
respons
system
corticosteroid
effect
reduc
length
hospit
shorten
durat
respiratori
failur
find
consist
observ
suggest
aberr
immun
respons
superimpos
chronic
type
immun
copd
respons
respiratori
compromis
specif
system
topic
corticosteroid
may
suppress
product
therebi
allevi
airway
hyperrespons
mucu
hyperproduct
induc
cytokin
although
studi
requir
corticosteroid
may
potenti
promot
elimin
respiratori
virus
inhibit
aberr
allerg
immun
respons
secret
viral
proteinas
discoveri
allergen
natur
rhinoviru
proteinas
addit
respons
expand
list
highli
allergen
proteinas
potenti
relev
human
respiratori
tract
diseas
includ
proteinas
fungal
plant
dust
mite
origin
howev
recent
shown
common
dust
mite
proteinas
isol
human
environ
fail
retain
proteinas
activ
requir
allergen
therefor
environment
proteinas
greatest
proxim
relev
human
respiratori
diseas
may
confin
deriv
plant
fungal
sourc
shown
virus
interestingli
although
studi
reveal
allergen
potenti
multipl
proteinas
also
clear
proteinas
equival
allergen
potenti
perhap
best
exemplifi
rhinovir
proteinas
rel
proteinas
demonstr
weak
allergen
activ
nonetheless
find
support
content
proteinas
crucial
virul
factor
allerg
diseas
elicit
divers
organ
superimposit
allerg
inflamm
preexist
diseas
might
expect
compound
airway
obstruct
multipl
nonredund
mechan
therebi
lead
clinic
deterior
regard
find
mix
immun
aecopd
may
indic
role
host
antigen
present
cell
sens
viral
proteinas
skew
immun
respons
toward
exact
mechan
involv
condit
antigen
present
cell
toward
respons
current
unknown
remain
intens
area
investig
copd
patient
acut
respiratori
failur
show
mix
immun
respons
local
lung
system
pbmc
human
rhinovirus
hrv
frequent
isol
lung
respiratori
failur
hrvencod
proteinas
activ
dendrit
cell
skew
cell
develop
toward
pole
bal
fluid
collect
three
group
control
copd
stabl
copd
exacerb
requir
mechan
ventil
store
batch
analyz
use
multiplex
quantit
cytokin
bead
assay
r
system
verifi
quantit
elisa
b
c
mig
e
half
subject
group
show
detect
level
consist
detect
bal
fluid
copd
exacerb
subject
group
compar
control
subject
statist
analysi
perform
use
mannwhitney
test
cell
isol
pbmc
volunt
baselin
free
symptom
upper
lower
respiratori
infectionexacerb
cocultur
autolog
irradi
apc
ratio
supernat
cocultur
assay
collect
store
batch
analyz
use
multiplex
quantit
cytokin
bead
assay
verifi
quantit
cytokin
data
show
individu
respons
baselin
control
b
copd
iii
c
copd
iiiiv
time
upper
respiratori
infect
exacerb
elisa
top
middl
lower
panel
baselin
cytokin
level
group
compar
exacerb
data
point
cohort
statist
analysi
perform
use
mannwhitney
test
monocyt
peripher
blood
copd
patient
healthi
control
cultur
gmcsf
day
induc
monocyt
deriv
dc
modc
modc
treat
indic
stimuli
buffer
rhinoviru
proteinas
lipopolysaccharid
lp
hr
analyz
surfac
dc
matur
marker
express
cytokin
product
upregul
hladr
b
measur
flow
cytometri
indic
valu
scatter
plot
show
mean
fluoresc
intens
express
hladr
dc
treatment
data
repres
mean
sd
ten
independ
experi
dc
cultur
supernat
analyz
presenc
tnf
c
multiplex
cytokin
assay
system
undetect
level
found
statist
analysi
perform
use
twotail
wilcoxon
sign
rank
test
age
sex
match
mice
n
group
immun
intranas
ova
recombin
buffer
pb
everi
day
total
day
h
last
immun
mice
assess
b
ahr
shown
dose
respons
acetylcholin
use
pc
c
bal
differenti
cell
lung
specif
elispot
e
ovaspecif
serum
f
lung
lavag
glycoprotein
determin
group
mice
p
rel
pb
buffer
p
rel
pb
buffer
use
one
way
anova
ttest
data
repres
mean
valu
sd
concentr
g
h
j
k
tnf
l
measur
supernat
singl
cell
cultur
lung
cell
use
luminex
p
rel
buffer
p
rel
buffer
use
one
way
anova
ttest
data
repres
three
independ
experi
valu
shown
mean
valu
sd
